PATENT CLAIM ANALYSIS

Application Number: 15771816
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "171000"]

Abstract:
The invention provides synergistic combinations of cannabidiol (CBD) and a second therapeutic agent, such as one or more ChEH/AEBS inhibitors, a naphthoquinone or a derivative thereof, or any combination thereof, effective for the treatment cancer. Compositions containing same and methods of use of same are described.

Claim (Index 35):
The method of  claim 34 , wherein said unsaturated fatty acid is oleic acid, arachidonic acid (ARA) or docosahexaenoic acid (DHA) or a combination thereof.

Metadata:
- Claim Count in Document: 129.0
- Percentile: 91.0
- Lexical Diversity: 1.31707
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13690920', '15549496', '11920909', '13953013', '14792046']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.729113717290699
- 35 USC 102 Novelty (BERT): 0.5327476940379726
- Combined Prediction Score: 0.7094771149654263
- Mean Citation Score: 230.085884
- Max Citation Score: 235.90778
- Similarity Product: 109.19646953808608

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test